Status:
COMPLETED
Rapid Acute Coronary Syndrome Exclusion Using High-sensitivity I Troponin
Lead Sponsor:
Henry Ford Health System
Collaborating Sponsors:
Beckman Coulter, Inc.
Conditions:
Chest Pain
Myocardial Ischemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
As part of the planned implementation of a new clinical pathway using hs-cTnI, the investigators will measure patient outcomes and clinical processes in a real-world scenario throughout an integrated ...
Detailed Description
This is a pragmatic, implementation study testing the implications of a real-world execution of a rapid evaluation pathway for suspected ACS using the Beckman hs-cTnI assay. As the new protocol is exe...
Eligibility Criteria
Inclusion
- Patients ≥18 years old presenting to the ED for whom a treating clinician suspects ACS and orders a baseline ECG and cardiac troponin.
Exclusion
- ST-segment Myocardial Infarction (STEMI) leading to immediate reperfusion therapy
- Any ED-drawn hs-cTnI value \> 99th percentile (18 ng/L)
- Clear traumatic cause for symptoms (e.g., direct chest wall trauma, motor vehicle accident)
- A transfer from another facility
- Primary residence outside the state of Michigan
- Previous inclusion in the study
- Enrolled in hospice
Key Trial Info
Start Date :
July 29 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 3 2022
Estimated Enrollment :
32609 Patients enrolled
Trial Details
Trial ID
NCT04488913
Start Date
July 29 2020
End Date
March 3 2022
Last Update
March 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Health System
Detroit, Michigan, United States, 48202